$14.46
-0.42-2.85%
Last update: Oct 30, 4:17 AM
Ascentage Pharma Group International (AAPG) Stock Price, Quote, News & History
AAPGNASDAQ
William Blair sees major upside for Ascentage Pharma stock as the cancer drug developer approaches three pivotal trial results in 2027.
You can purchase shares of Ascentage Pharma Group (NASDAQ:AAPG) through any online brokerage.
Other companies in Ascentage Pharma Group’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Ascentage Pharma Group has a consensus price target of $44.56.
The stock price for Ascentage Pharma Group (NASDAQ: AAPG) is $14.5 last updated October 30, 2026 at 4:17 AM EDT.
There are no upcoming dividends for Ascentage Pharma Group.
Ascentage Pharma Group does not have any upcoming earnings scheduled.
There is no upcoming split for Ascentage Pharma Group.
Ascentage Pharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing...
